Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Mar 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3761900018 | Cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 mg prolonged-release oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3761901019 | Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Product containing cyclobenzaprine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has active ingredient | Cyclobenzaprine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has active ingredient | Cyclobenzaprine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has manufactured dose form | Extended-release capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has manufactured dose form | Prolonged-release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Product containing cyclobenzaprine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has basis of strength substance | Cyclobenzaprine | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength numerator value | 30 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength denominator unit | Capsule | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has precise active ingredient | Cyclobenzaprine hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Product containing only cyclobenzaprine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR